IPCA Laboratories share news, announcements and annual reports
NSE: IPCALABBSE: 524494Pharmaceuticals & BiotechnologyMid Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,926.20.
30 Oct: open ₹1,945.20, high ₹1,964.90, low ₹1,921.40
- Next results date: the board meets on 5 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹48,909 Cr229th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 37.34
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 6.07
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.31%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 17.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.07
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,53,52767.6% delivered
IPCA Laboratories share news and announcements
772 announcements, routine notices left out, newest first. Page 2 of 16.
Aug 2025
11 Aug · Meeting
11 Aug · Results
5 Aug · Analysts
Jul 2025
24 Jul · Board meeting
11 Jul · Corporate action
11 Jul · Meeting
7 Jul · Rating
Jun 2025
16 Jun · Management
16 Jun · Analysts
16 Jun · General Updates
May 2025
29 May · Results
23 May · Analysts
Apr 2025
Mar 2025
28 Mar · General Updates
28 Mar · Board meeting
Feb 2025
13 Feb · Results
13 Feb · Results
13 Feb · Board meeting
10 Feb · Analysts
7 Feb · General Updates
5 Feb · General Updates
Jan 2025
29 Jan · General Updates
27 Jan · Board meeting
16 Jan · General Updates
Dec 2024
19 Dec · Legal
The exchange asked on 18 Dec 2024
Nov 2024
18 Nov · Updates
14 Nov · Board meeting
14 Nov · Results
8 Nov · Analysts
Oct 2024
24 Oct · Corporate action
Sep 2024
30 Sep · Board meeting
20 Sep · Management
Aug 2024